Pan Zenggang, Xu Mina L
Department of Pathology, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06510-3218, USA.
Department of Pathology, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06510-3218, USA; Department of Laboratory Medicine, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06510-3218, USA.
Surg Pathol Clin. 2019 Sep;12(3):805-829. doi: 10.1016/j.path.2019.03.013. Epub 2019 Jun 8.
Histiocytic and dendritic cell neoplasms are very rare, belonging to a group that share morphologic, immunophenotypic, and ultrastructural characteristics of mature histiocytic/dendritic neoplasms. Histiocytic and dendritic cell neoplasms may arise de novo or in association with B-cell, T-cell, or myeloid neoplasms. Recent molecular findings, particularly the discoveries of the mutations in the RAS-RAF-MEK-ERK pathway, have greatly advanced the diagnosis and treatment options. Histiocytic and dendritic cell neoplasms may closely resemble each other, non-hematopoietic neoplasms, and even reactive processes. Therefore, it is essential to understand the clinicopathologic characteristics, differential diagnoses, and pitfalls of each entity.
组织细胞和树突状细胞肿瘤非常罕见,属于一组具有成熟组织细胞/树突状细胞肿瘤的形态学、免疫表型和超微结构特征的肿瘤。组织细胞和树突状细胞肿瘤可原发出现或与B细胞、T细胞或髓系肿瘤相关。最近的分子研究发现,特别是RAS-RAF-MEK-ERK途径突变的发现,极大地推动了诊断和治疗选择。组织细胞和树突状细胞肿瘤可能彼此非常相似,与非造血性肿瘤甚至反应性过程相似。因此,了解每个实体的临床病理特征、鉴别诊断和陷阱至关重要。